Topical Gene Therapy Vyjuvek & Cancer Drug Lynozyfic Among Four New Products Set For EU Market

 
• By Eliza Slawther
  
Four products were backed for approval by the EMA this week (Shutterstock)

More from EU CHMP

More from Pathways & Standards